Cumberland Pharmaceuticals is a pharmaceutical company that acquires, develops and commercializes prescription pharmaceutical products. Co.'s portfolio of brands includes: Acetadote® (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor® (ibuprofen) injection, for the treatment of pain and fever; Kristalose® (lactulose) for oral solution, for the treatment of constipation; Omeclamox-Pak®, (omeprazole, clarithromycin, amoxicillin) oral, for the treatment of Helicobacter pylori infection and related duodenal ulcer disease; and Vaprisol® (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia. The CPIX stock yearly return is shown above.
The yearly return on the CPIX stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the CPIX annual return calculation with any dividends reinvested as applicable (on ex-dates).
|